RHH646

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RHH646, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RHH646 for Knee Osteoarthritis [Phase 2]